A multisite phase II clinical trial launched this month in the United States to evaluate the safety and efficacy of a proprietary line of stem cells for treating patients in the early stages of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
Researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting revealed how a protein encourages the production of stem cells that regenerate damaged tissues of the heart following an acute attack (myocardial infarction).
Scientists from Queen Mary University of London have shown that stem cell behavior can be modified by manipulating the nanoscale properties of the material they are grown on— improving the potential of regenerative medicine and tissue engineering as a result.
A new study shows that cycles of prolonged fasting not only protect against immune system damage—a major side effect of chemotherapy—but also induce immune system regeneration by shifting stem cells from a dormant state to one of self-renewal.
Researchers at the University of Missouri (UM) have shown that a new line of genetically modified pigs will host transplanted cells without the risk of rejection.
StemCells Inc., Newark, CA has transplanted its proprietary HuCNS-SC® purified human neural stem cells into the first five patients in the final cohort of its 16-patient phase I/II trial for geographic atrophy of age related macular degeneration (GA-AMD).
Two years ago researchers found a new type of stem cell in the brain that has the capacity to form new cells. A follow-up study now reveals that these same stem cells are directly involved in the reaction of the brain after stroke.
Scientists have uncovered a potential solution for how to more effectively kill tumor cells using cancer-killing viruses.
Two news studies show science is moving closer to developing treatments from stem cells for those suffering from neural-related conditions including multiple sclerosis (MS) and Alzheimer’s disease.
Scientists have merged stem cell and “organ-on-a-chip” technologies to grow functioning human heart tissue carrying an inherited cardiovascular disease.